Oncology
Revealing the molecular mechanism of tumor development and identifying the matching inhibitory candidates is one important area within the cancer research.
The tumor diversity is extremely high. Therefore, cancer research belongs to the high variant research areas with manifold scientific approaches.
To match this challenge, we offer you a unique diversity of products for your oncology research and development in the academic and pharmaceutical field.
Click on the organs and learn more about cancer types
General information
Oncologists focus on the diagnosis, therapy and follow-up of cancer.
Cancer is a class of diseases in which cells start to divide uncontrollably and invade other tissues. Cancer cells can spread to other parts of the body via the blood and lymphatic system. Under physiological conditions, cell proliferation is tightly controlled by many mechanisms. In addition, the immune system is able to recognize and destroy cancer cells. If these mechanisms fail or the immune system cannot effectively destroy the cells, it can lead to a malignant tumor. Theoretically, a malignant neoplasm can occur everywhere, but there are cancers that are more often than others. For men it is the prostate and in women it is the mammary gland.
Relevant products for oncology research
| Name | Price | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| PAK1 Antibody (Phospho-Thr212) | Login | PAK1 Antibody (Phospho-Thr212) | ||||||||||||||||
|
||||||||||||||||||
| PARK2 Antibody (Phospho-Ser131) | Login | PARK2 Antibody (Phospho-Ser131) | ||||||||||||||||
|
||||||||||||||||||
| PAK7 Antibody - C-terminal region | Login | PAK7 Antibody - C-terminal region | ||||||||||||||||
|
||||||||||||||||||
| PAK7 Antibody | Login | PAK7 Antibody | ||||||||||||||||
|
||||||||||||||||||
| RBL1 Antibody (Phospho-Thr369) | Login | RBL1 Antibody (Phospho-Thr369) | ||||||||||||||||
|
||||||||||||||||||
| RPS6KB1 Antibody (Phospho-Thr421) | Login | RPS6KB1 Antibody (Phospho-Thr421) | ||||||||||||||||
|
||||||||||||||||||
| RPS6KB1 Antibody (Phospho-Thr412) | Login | RPS6KB1 Antibody (Phospho-Thr412) | ||||||||||||||||
|
||||||||||||||||||
| RPS6KB1 Antibody (Phospho-Ser434) | Login | RPS6KB1 Antibody (Phospho-Ser434) | ||||||||||||||||
|
||||||||||||||||||
| RPS6KB1 Antibody (Phospho-Ser371) | Login | RPS6KB1 Antibody (Phospho-Ser371) | ||||||||||||||||
|
||||||||||||||||||
| TP53 Antibody (Phospho-Ser392) | Login | TP53 Antibody (Phospho-Ser392) | ||||||||||||||||
|
||||||||||||||||||
| TP53 Antibody - C-terminal region | Login | TP53 Antibody - C-terminal region | ||||||||||||||||
|
||||||||||||||||||
| TP73 Antibody (Phospho-Tyr99) | Login | TP73 Antibody (Phospho-Tyr99) | ||||||||||||||||
|
||||||||||||||||||
| OTUB2 Antibody - middle region | Login | OTUB2 Antibody - middle region | ||||||||||||||||
|
||||||||||||||||||
| SRCIN1 Antibody - middle region | Login | SRCIN1 Antibody - middle region | ||||||||||||||||
|
||||||||||||||||||
| CDK5R2 Antibody - middle region | Login | CDK5R2 Antibody - middle region | ||||||||||||||||
|
||||||||||||||||||
| BCAR1 Antibody (Phospho-Tyr410) | Login | BCAR1 Antibody (Phospho-Tyr410) | ||||||||||||||||
|
||||||||||||||||||
| BCAR1 Antibody (Phospho-Tyr249) | Login | BCAR1 Antibody (Phospho-Tyr249) | ||||||||||||||||
|
||||||||||||||||||
| BCAR1 Antibody (Phospho-Tyr165) | Login | BCAR1 Antibody (Phospho-Tyr165) | ||||||||||||||||
|
||||||||||||||||||
| PLCG2 Antibody (Phospho-Tyr753) | Login | PLCG2 Antibody (Phospho-Tyr753) | ||||||||||||||||
|
||||||||||||||||||
| PLCG2 Antibody (Phospho-Tyr1217) | Login | PLCG2 Antibody (Phospho-Tyr1217) | ||||||||||||||||
|
||||||||||||||||||
| PLD2 Antibody (Phospho-Tyr169) | Login | PLD2 Antibody (Phospho-Tyr169) | ||||||||||||||||
|
||||||||||||||||||
| PML Antibody - N-terminal region | Login | PML Antibody - N-terminal region | ||||||||||||||||
|
||||||||||||||||||
| PMS1 Antibody - middle region | Login | PMS1 Antibody - middle region | ||||||||||||||||
|
||||||||||||||||||
| PMS2 Antibody - middle region | Login | PMS2 Antibody - middle region | ||||||||||||||||
|
||||||||||||||||||
| PPARG Antibody | Login | PPARG Antibody | ||||||||||||||||
|
||||||||||||||||||


